-
Mashup Score: 16
Debabrata Mukherjee, MD, FACC
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 44GLP1RAs in Clinical Practice: Therapeutic Advances and Safety Perspectives - American College of Cardiology - 3 day(s) ago
Health care professionals should explore the use of glucagon-like peptide-1 receptor agonists (GLP1RAs) for cardiovascular risk reduction and their broader impacts on cardiometabolic health beyond diabetes mellitus management, guided by the latest clinical trial findings and guidelines. Clinicians should be vigilant for gastrointestinal tract adverse effects in patients using GLP1RAs, advising gradual dose escalation and employing toolkits to improve tolerability. Glucagon-like peptide-1 is an incretin
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 88Who to Select For Treatment With Semaglutide: A Look at the SELECT Trial - American College of Cardiology - 14 day(s) ago
At the American Heart Association’s (AHA) Scientific Sessions 2023, the Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) trial 1 was presented demonstrating that 2.4mg once weekly subcutaneous semaglutide in adults with atherosclerotic cardiovascular disease (ASCVD) and body mass index ≥ 27 kg/m 2 but no diabetes mellitus (DM) resulted in 20% reduction in death from cardiovascular (CV) causes, nonfatal myocardial infarction, or nonfatal stroke over a mean
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 31New PREVENT Equations for CVD Risk Assessment: Key Takeaways - American College of Cardiology - 15 day(s) ago
Elizabeth A. Jackson, MD, FACC
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 9Clinical Decision Support for Hypertension Management in CKD - American College of Cardiology - 23 day(s) ago
Dustin D Spencer, PharmD
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 65A systematic review and cluster analysis approach of 103 studies of high-intensity interval training on cardiorespiratory fitness - 27 day(s) ago
AbstractAims. This study aims to systematically review the systematic reviews and meta-analyses examining the effect of high-intensity interval training (HIIT)
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 7
Elizabeth A. Jackson, MD, FACC
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 9
A groundbreaking new study found the presence of microplastics and nanoplastics in human arterial plaque. The presence of microplastics in plaque was associated with a 4.5 fold increase in risk of heart attack, stroke, and death.
Source: www.healthline.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Microplastics and Nanoplastics in Atheromas and CV Events - American College of Cardiology - 1 month(s) ago
Debabrata Mukherjee, MD, FACC
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 5Engineering blood and lymphatic microvascular networks - 1 month(s) ago
The human vasculature plays a crucial role in the blood supply of nearly all organs as well as the drainage of the interstitial fluid. Consequently, if these physiological systems go awry, pathological changes might occur. Hence, the regeneration of existing vessels, as well as approaches to engineer artificial blood and lymphatic structures represent current challenges within the field of vascular research. In this review, we provide an overview of both the vascular blood circulation and the long-time neglected but equally important lymphatic system, with regard to their organotypic vasculature.
Source: www.atherosclerosis-journal.comCategories: General Medicine News, CardiologistsTweet
What is the effect of SGLT2i on the risk of major adverse CV events and its individual components, overall and within clinically relevant subgroups of patients, irrespective of ASCVD, diabetes, and kidney function? Read the journal scan: https://t.co/EfSYpkIQwo #cvPrev